Institution: | (1) Department of Immunohaematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands;(2) Department of Immunology, University of Tuebingen, Tuebingen, Germany;(3) Centre for Medical Research, University of Tuebingen, Tuebingen, Germany;(4) Cancer Sciences Division, Southampton University Hospitals, Southampton, UK;(5) Immatics Biotechnologies, Tuebingen, Germany;(6) Skin Cancer Unit of the German Cancer Research Centre, University Clinics of Mannheim, Mannheim, Germany;(7) Paul-Ehrlich-Institute, Langen, Germany;(8) Department of Haematology and Oncology, University of Regensburg, Regensburg, Germany;(9) Department of Haematology, Centre for Cancer Immune Therapy, Herlev, Denmark;(10) Third Department of Internal Medicine, University of Ulm, Ulm, Germany;(11) Clinical Immunology Department, Medical University of Lublin, Lublin, Poland;(12) Research Department, Kantonal Hospital St Gallen, St Gallen, Switzerland;(13) Department of Haematology and Oncology, Freiburg University Medical Centre, Freiburg, Germany;(14) Third Medical Department, University Mainz, Mainz, Germany;(15) Department of Clinical Oncology, Leiden University Medical Center, Leiden, The Netherlands |